Determination of matrine in medicine and bio-fluids based on inhibition of luminol-myoglobin chemiluminescence

A green, rapid and sensitive flow injection procedure based on the inhibition of the chemiluminescence (CL) intensity from the luminol-myoglobin (Mb) system is proposed for the determination of matrine. The decrement of CL signal was linear with the logarithm of the matrine concentration over the range from 10 to 1000 ng/mL (R ² = 0.9978) offering a detection limit of 3.5 ng/mL. At a flow rate of 2.0 mL/min, one analysis cycle, including sampling and washing, could be accomplished in 0.5 min with a relative standard deviation (RSD) of less than 5.0%. The sensitive flow injection method was successfully applied to the determination of matrine in pharmaceutical injection and human serum, with recoveries from 94.1 to 113.4% and RSDs of less than 5.0%.